INSIGHTS ON CLINICAL TRIAL PARTNERING
-
How RFI/RFP Optimization Changes The Game
Selecting the right vendors can determine whether a clinical trial advances smoothly or stalls under budget overruns and delays.
-
The Vendor Selection Blunder: An Expensive Oversight In Clinical Trials
Vendor selection isn’t just procedural — it shapes trial outcomes. Even with a solid process, missteps can ripple through timelines, budgets, and team morale. Choose wisely.
-
Quotient Sciences Capacity Update July 2025
Explore how expedited review pathways can be strategically used to accelerate development while mitigating CMC risks.
-
Navigating The 7 Biggest Challenges In Rare Disease Clinical Trials
Discover how partnering with specialized rare disease CROs allows drug sponsors to accelerate treatment development, navigate trial complexities, and ultimately improve patient outcomes.
-
Choose eClinical Software Built for the Full Study Lifecycle, Not Just Startup3/25/2026
This clip explores why choosing an RTSM partner requires more than fast startup timelines, highlighting how long‑term flexibility and operational durability matter far more once a study is underway.
-
The State Of eSource Adoption In Clinical Trials5/12/2026
Learn how eSource-ready sites are improving trial efficiency, reducing site burden, and becoming essential to modern clinical trial execution.
-
Go From Three Meetings To One With AI-Enabled eCOA5/5/2026
Learn how to turn three meetings into one with AI that is streamlining clinical workflows by reducing redundant steps, simplifying site operations, and accelerating data collection.
-
Breaking Down Early Small Molecule Development3/11/2026
Adopt an integrated development strategy to streamline the path from early development to the clinic, ensuring timely clinical supply while reducing delays, risk, and inefficiencies.
-
Redefining eSource: A Smarter Approach To Clinical Trial Data Capture3/26/2026
Discover how AI-powered extraction and site-centric workflows improve data quality and reduce administrative burdens for research teams.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Clinical trial portals should reduce friction—not add it. Streamlined tools empower sites, support patients, and give sponsors visibility without micromanagement or unnecessary complexity.
-
Navigating drug safety in the era of innovation-driven medicine
The focus on drug safety and pharmacovigilance has never been more intense. Patient safety remains paramount throughout a product's lifecycle, even as sponsors and marketing authorization holders (MAHs) face increasing complexity in managing safety data. This complexity stems from huge volumes of data generated from scores of diverse sources, much of it rapidly expanding unstructured data. Innovation-driven medicine is a key factor. These dynamics are reshaping the landscape of drug safety, presenting both challenges and opportunities for innovation in pharmacovigilance practices.
-
How can Ergomed use its oncology expertise, global reach, and access to patients with rare and ultra-rare diseases can help your organization achieve efficient, high-quality clinical trial execution?
-
Successfully navigating the complexities of bladder cancer research means mastering specialized delivery methods, managing supply constraints, and leveraging deep site relationships across all phases.
-
With integrations at the heart of our efficiency model, Block Clinical automates payments in three areas: Site Payments, Patient Payments, and Supplier Payments.